These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 29772705)

  • 1. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
    Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer.
    Jin Y; Zhu H; Cai W; Fan X; Wang Y; Niu Y; Song F; Bu Y
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1.
    You W; Chen B; Liu X; Xue S; Qin H; Jiang H
    Sci Rep; 2017 Apr; 7(1):591. PubMed ID: 28377627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
    Xiong YC; Wang J; Cheng Y; Zhang XY; Ye XQ
    Mol Cell Biochem; 2020 May; 468(1-2):185-193. PubMed ID: 32200471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
    Liu H; Gu Y; Wang H; Yin J; Zheng G; Zhang Z; Lu M; Wang C; He Z
    Oncotarget; 2015 Jun; 6(17):14913-25. PubMed ID: 25945834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.
    Tang H; Lv W; Sun W; Bi Q; Hao Y
    Int J Mol Med; 2019 Mar; 43(3):1203-1216. PubMed ID: 30628663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
    Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
    Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer.
    Chen B; Tan Z; Gao J; Wu W; Liu L; Jin W; Cao Y; Zhao S; Zhang W; Qiu Z; Liu D; Mo X; Li W
    J Exp Clin Cancer Res; 2015 Oct; 34():126. PubMed ID: 26490682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.
    Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z
    Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.
    Liao L; Yu H; Ge M; Zhan Q; Huang R; Ji X; Liang X; Zhou X
    Thorac Cancer; 2019 May; 10(5):1203-1212. PubMed ID: 30977310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways.
    Zhang B; Tao F; Zhang H
    Mol Med Rep; 2018 Apr; 17(4):4899-4908. PubMed ID: 29393472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
    Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non-Small Cell Lung Cancer Cells.
    Day TF; Kallakury BVS; Ross JS; Voronel O; Vaidya S; Sheehan CE; Kasid UN
    Mol Cancer Res; 2019 May; 17(5):1207-1219. PubMed ID: 30647104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression.
    Jin H; Jang Y; Cheng N; Li Q; Cui PF; Zhou ZW; Jiang HL; Cho MH; Westover KD; Tan QY; Xu CX
    J Exp Clin Cancer Res; 2019 Apr; 38(1):165. PubMed ID: 30987652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
    Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
    Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The depletion of PinX1 involved in the tumorigenesis of non-small cell lung cancer promotes cell proliferation via p15/cyclin D1 pathway.
    Tian XP; Jin XH; Li M; Huang WJ; Xie D; Zhang JX
    Mol Cancer; 2017 Apr; 16(1):74. PubMed ID: 28372542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression.
    Tu W; Yang B; Leng X; Pei X; Xu J; Liu M; Dong Q; Tao D; Lu Y; Liu Y; Yang Y
    Cancer Sci; 2019 May; 110(5):1573-1586. PubMed ID: 30815935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired AKT signaling and lung tumorigenesis by PIERCE1 ablation in KRAS-mutant non-small cell lung cancer.
    Roh JI; Lee J; Sung YH; Oh J; Hyeon DY; Kim Y; Lee S; Devkota S; Kim HJ; Park B; Nam T; Song Y; Kim Y; Hwang D; Lee HW
    Oncogene; 2020 Sep; 39(36):5876-5887. PubMed ID: 32728173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F; Zhao Y; Liu J
    Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.